International Journal of Gynecological Cancer

Papers
(The H4-Index of International Journal of Gynecological Cancer is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Inguinofemoral lymphadenectomy technique in 10 steps406
The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women’s cancer research organization192
The Cukurova score in the prediction of primary cytoreduction in ovarian cancer141
Successful cervical cancer treatment during a monochorionic diamniotic twin pregnancy in a patient with history of preterm delivery99
Well-differentiated papillary mesothelial tumor of the peritoneum90
Complementary use of indocyanine green and technetium to enhance sentinel lymphadenectomy in vulvar cancer85
Surgical technique and surgeon volume: the pursuit of data-driven outcomes60
Best original research presented at the 25th European Congress on Gynaecological Oncology: best of ESGO 202460
A population-based study of outcomes in adjuvant radiotherapy for stage II endometrial carcinoma60
Surgical staging for locally-advanced cervical cancer: the answer remains ‘NO’60
O021/#374 Breast cancer patients are at increased risk of devoleping uterine serous cancer: implication for conseling – a seer analysis59
Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico58
Authors’ response to: “Methodological concerns regarding AGO score validation in low-grade ovarian cancers”58
22nd meeting of the European Society of Gynaecological Oncology (ESGO 2021) report51
Utilization of artificial intelligence to mitigate health inequalities in gynecological cancer care49
CERVICAL MELANOMA WITH CEREBRAL DISSEMINATION: A DIAGNOSTIC AND THERAPEUTIC CHALLENGE IN GYNECOLOGIC ONCOLOGY48
HYPOFRACTIONATED RADIATION THERAPY WITH ADAPTIVE PLANNING FOR THE TREATMENT OF ENDOMETRIAL AND CERVICAL CANCER (HERA TRIAL)47
HIDDEN IN PLAIN SIGHT: DESMOPLASTIC SMALL ROUND CELL TUMOUR (DSRCT) PRESENTING AS A GYNAECOLOGICAL MALIGNANCY47
COST-UTILITY ANALYSIS OF A MOLECULAR-INTEGRATED-PROFILE FOR WOMEN WITH (HIGH)INTERMEDIATE RISK ENDOMETRIAL CANCER - PORTEC-4A AN INTERNATIONAL, MULTICENTRE, RANDOMISED, PHASE 3 TRIAL45
INTRA-OPERATIVE COMPLICATIONS OF GYNECOLOGIC ONCOLOGY SURGERIES IN A TEACHING HOSPITAL IN SUB-SAHARAN AFRICA: EXPERIENCE FROM ADDIS ABABA, ETHIOPIA45
LOWER LIMB LYMPHEDEMA AFTER TREATMENT OF CERVICAL CARCINOMA AND ITS IMPACT ON QUALITY OF LIFE44
COLPOSCOPIC-HISTOLOGIC DIAGNOSTIC AGREEMENT IN CERVICAL INTRAEPITHELIAL NEOPLASIA 2+: A FIVE-YEAR REVIEW OF COLPOSCOPIC SERVICES AT THE NATIONAL HOSPITAL ABUJA, NIGERIA COLPOSCOPIC-HISTOLOGIC DIAGNOST43
THE LANDSCAPE OF VULVAR CANCER SURVIVAL AND TREATMENT CHARACTERISTICS IN BOTSWANA41
SIGNIFICANCE & CLINICAL UTILITY OF 2-DEOXY-2-[18F] FLUORO-D-GLUCOSE-POSITRON EMISSION TOMOGRAPHY HIBRID IMAGING IN THE DIAGNOSIS & RESPONSE EVALUATION IN CERVIX CANCER.41
A POTENTIAL BLIND SPOT FOR ANTIBODY–DRUG CONJUGATES TARGETING FOLATE RECEPTOR-140
PEMBROLIZUMAB PLUS CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB IN PARTICIPANTS WITH PERSISTENT, RECURRENT, OR METASTATIC CERVICAL CANCER: 5-YEAR FOLLOW-UP RESULTS FROM KEYNOTE-82640
2022-RA-1495-ESGO Differential metabolism of estrogens in model cell lines and tissues of HGSOC subtypes38
2022-RA-1127-ESGO The efficacy of MEK inhibitors in the treatment of low-grade serous ovarian cancers: a systematic review37
2022-RA-981-ESGO Can misdiagnosis be avoided in case of intestinal-type carcinoma of the vagina?A literature comprehensive review37
2022-RA-1001-ESGO Analysis of postoperative wound infections in malignancies of the female internal tract37
2022-RA-630-ESGO Overexpression of PDEA1 is a predictive biomarker for platinum resistance and poor prognosis in epithelial ovarian cancer by regulating cell cycle35
2022-RA-1690-ESGO Rare uterine cervical adenocarcinomas in salah azaiez institute: clinicopathological features35
2022-RA-1318-ESGO Immunohistochemical profiling of macrophage subtypes in the microenvironment of ovarian tumours in young women33
0.39570903778076